South Africa Variant May Evade Antibodies Taken From People Who Recovered From “Original Form” Of SARS-CoV-2

Newsweek (1/20, Gander) reports the 501Y.V2 variant, also known as the South Africa variant, can evade antibodies taken from people who developed them against “the original form of” the virus, “prompting fears vaccines may not work against it.” The 501Y.V...